SURMATRIX Trademark

Trademark Overview


On Monday, April 7, 2025, a trademark application was filed for SURMATRIX with the United States Patent and Trademark Office. The USPTO has given the SURMATRIX trademark a serial number of 99124349. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 7, 2025. This trademark is owned by Surgenex Holdings, LLC. The SURMATRIX trademark is filed in the Pharmaceutical Products category with the following description:

Amniotic liquid allograft; Liquid biological preparations derived from human amnion, amniotic fluid and umbilical cord for medical and therapeutic use; Processed human donor skin for the replacement of soft tissue; injectable flowable human amniotic membrane allograft; flowable allograft tissue matrix derived from donated human amniotic membrane; Bone graft putty derived from demineralized bone matrix (DBM); Implantable living tissue, namely, bone, demineralized bone matrix, and derivatives of demineralized bone powder; Bone grafting products, namely, bone implants comprised of living tissue; Bone regenerating products comprised of living tissue, namely, demineralized bone matrix and derivatives of demineralized bone powder; Human allograft bone and tissue; Human allograft tissue in the nature of demineralized bone matrix used for use in surgical procedures; Surgical implants for the bone comprising living tissue in the nature of demineralized bone matrix for use in surgical procedures...
surmatrix

General Information


Serial Number99124349
Word MarkSURMATRIX
Filing DateMonday, April 7, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, April 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAmniotic liquid allograft; Liquid biological preparations derived from human amnion, amniotic fluid and umbilical cord for medical and therapeutic use; Processed human donor skin for the replacement of soft tissue; injectable flowable human amniotic membrane allograft; flowable allograft tissue matrix derived from donated human amniotic membrane; Bone graft putty derived from demineralized bone matrix (DBM); Implantable living tissue, namely, bone, demineralized bone matrix, and derivatives of demineralized bone powder; Bone grafting products, namely, bone implants comprised of living tissue; Bone regenerating products comprised of living tissue, namely, demineralized bone matrix and derivatives of demineralized bone powder; Human allograft bone and tissue; Human allograft tissue in the nature of demineralized bone matrix used for use in surgical procedures; Surgical implants for the bone comprising living tissue in the nature of demineralized bone matrix for use in surgical procedures; Biological demineralized bone matrix tissue intended for subsequent implantation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 7, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSurgenex Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressScottsdale, AZ 85260

Trademark Events


Event DateEvent Description
Monday, April 7, 2025NEW APPLICATION ENTERED
Monday, April 7, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 7, 2025APPLICATION FILING RECEIPT MAILED